Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Tax Provisions: 2022-2024

Historic Tax Provisions for Amylyx Pharmaceuticals (AMLX) over the last 3 years, with Dec 2024 value amounting to -$770,000.

  • Amylyx Pharmaceuticals' Tax Provisions fell 151.40% to -$1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.7 million, marking a year-over-year decrease of 48.25%. This contributed to the annual value of -$770,000 for FY2024, which is 114.67% down from last year.
  • According to the latest figures from FY2024, Amylyx Pharmaceuticals' Tax Provisions is -$770,000, which was down 114.67% from $5.2 million recorded in FY2023.
  • In the past 5 years, Amylyx Pharmaceuticals' Tax Provisions registered a high of $5.2 million during FY2023, and its lowest value of -$770,000 during FY2024.
  • Its 3-year average for Tax Provisions is $1.8 million, with a median of $774,000 in 2022.
  • Per our database at Business Quant, Amylyx Pharmaceuticals' Tax Provisions spiked by 578.29% in 2023 and then tumbled by 114.67% in 2024.
  • Yearly analysis of 3 years shows Amylyx Pharmaceuticals' Tax Provisions stood at $774,000 in 2022, then spiked by 578.29% to $5.2 million in 2023, then tumbled by 114.67% to -$770,000 in 2024.